SMITH & NEPHEW PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 961.8 GBX | -0.52% |
|
+0.06% | -10.82% |
| Apr. 11 | UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates | MT |
| Apr. 11 | Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal | MT |
Financials (USD)
| Sales 2024 * | 5.83B | Sales 2025 * | 6.13B | Capitalization | 10.51B |
|---|---|---|---|---|---|
| Net income 2024 * | 549M | Net income 2025 * | 703M | EV / Sales 2024 * | 2.24 x |
| Net Debt 2024 * | 2.55B | Net Debt 2025 * | 2.23B | EV / Sales 2025 * | 2.08 x |
| P/E ratio 2024 * |
20.5
x | P/E ratio 2025 * |
15.5
x | Employees | 18,452 |
| Yield 2024 * |
3.18% | Yield 2025 * |
3.56% | Free-Float | 99.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Smith & Nephew Plc
More recommendations
More press releases
More news
| 1 day | -1.18% | ||
| 1 week | -0.46% | ||
| Current month | -3.51% | ||
| 1 month | -9.57% | ||
| 3 months | -12.94% | ||
| 6 months | +3.91% | ||
| Current year | -11.28% |
1 week
946.00
990.40
1 month
946.001 058.00
Current year
946.001 181.50
1 year
887.001 316.75
3 years
887.001 601.50
5 years
887.002 023.00
10 years
871.002 023.00
| Managers | Title | Age | Since |
|---|---|---|---|
Deepak Nath
CEO | Chief Executive Officer | - | 22-03-31 |
John Rogers
DFI | Director of Finance/CFO | 56 | Nov. 30 |
Alison Parkes
CMP | Compliance Officer | - | 99-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Marc E. Owen
BRD | Director/Board Member | 65 | 17-09-30 |
Jeremy Maiden
BRD | Director/Board Member | 62 | 23-09-13 |
Rupert Soames
CHM | Chairman | 63 | 23-04-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.16% | 16 M€ | -9.75% | ||
| 0.52% | 11 M€ | +0.83% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 961.8 | -0.52% | 1 722 121 |
| 24-04-18 | 966.8 | +0.69% | 6,772,326 |
| 24-04-17 | 960.2 | -0.19% | 2,567,634 |
| 24-04-16 | 962 | +0.35% | 4,653,030 |
| 24-04-15 | 958.6 | -0.27% | 2,903,863 |
Delayed Quote London S.E., April 19, 2024 at 05:09 am EDT
More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.05
USD
Average target price
16.43
USD
Spread / Average Target
+36.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.28% | 10.51B | |
| +9.35% | 125B | |
| -1.13% | 8.65B | |
| +18.54% | 7.31B | |
| +19.68% | 4.77B | |
| +7.75% | 3.42B | |
| -1.34% | 3.03B | |
| -16.08% | 1.97B | |
| -12.31% | 1.95B | |
| -30.20% | 1.62B |
- Stock Market
- Equities
- SN. Stock
